RPG Life Sciences Share Price | RPG Life Sciences Stock Screener
RPGLIFE
Pharmaceuticals
Share Price NSE
₹2937.00
▲
34.50 (1.19%)
Share Price BSE
₹2913.00
▲
10.65 (0.37%)
As of July 24, 2026, the RPG Life Sciences share price (NSE: RPGLIFE) is ₹2,937.00 on NSE and ₹2,913.00 on BSE, up 1.19% from the previous close, with shares trading between ₹2,800.00 and ₹3,010.20, and a 52-week range of ₹1,744.00–₹3,017.10.
Analyse RPGLIFE stock price history and track historical price performance.
Use the RPG Life Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
RPG Life Sciences Market Cap
₹4,946.82 Cr.
RPGLIFE P/E Ratio (TTM)
43.34
RPG Life Sciences P/B Ratio
8.25
EPS (TTM)
₹69.64
Dividend Yield
0.80%
Debt to Equity
0.02
RPGLIFE 52 Week High
₹3017.10
RPG Life Sciences 52 Week Low
₹1744.00
Operating Margin
19.00%
Profit Margin
15.79%
RPGLIFE Revenue (TTM)
₹190.00
EBITDA
₹46.00
Net Income
₹30.00
Total Assets
₹793.00
Total Equity
₹605.00
RPG Life Sciences Share Price Chart
Screen RPG Life Sciences share price with an interactive chart. Analyse RPGLIFE price trends and volatility across different timeframes.
RPG Life Sciences Company Profile - Fundamental Screener
Screen RPG Life Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for RPGLIFE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE105J01010
RPG Life Sciences Balance Sheet Screener
Screen RPGLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 |
|---|---|---|
| Assets | ||
| Total Assets | 793 | 658 |
| Current Assets | 560 | 465 |
| Fixed Assets | 197 | 172 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 27 | 7 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 605 | 531 |
| Share Capital | 13 | 13 |
| Reserves & Surplus | 592 | 517 |
RPG Life Sciences Income Statement Screener - Profit & Revenue Analysis
Screen RPG Life Sciences income statement and profit fundamentals.
Analyze RPGLIFE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for RPG Life Sciences share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Dec |
|---|---|---|---|---|---|---|
| Revenue | 190 | 258 | 166 | 197 | 183 | 176 |
| Expenses | 144 | 118 | 125 | 143 | 149 | 124 |
| EBITDA | 46 | 140 | 41 | 55 | 35 | 53 |
| Operating Profit % | 19.00% | 18.00% | 26.00% | 21.00% | 17.00% | 28.00% |
| Depreciation | 6 | 5 | 5 | 5 | 5 | 6 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 40 | 135 | 35 | 50 | 29 | 47 |
| Tax | 10 | 18 | 9 | 13 | 7 | 12 |
| Net Profit | 30 | 117 | 26 | 37 | 22 | 35 |
| EPS | 18.08 | 70.96 | 15.90 | 22.28 | 13.38 | 21.12 |
RPG Life Sciences Cash Flow Screener - Liquidity Fundamentals
Screen RPGLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March |
|---|---|---|
| Operating Activities | 57 | 78 |
| Investing Activities | 86 | -42 |
| Financing Activities | -21 | -27 |
| Net Cash Flow | 122 | 9 |
RPG Life Sciences Shareholding Pattern Screener
See RPG Life Sciences shareholding pattern with promoter, FII, and DII holdings.
Check RPG Life Sciences promoter holding and ownership changes for RPGLIFE on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.95% | 72.95% | 72.95% | 72.95% | 72.95% | 72.81% | 72.81% | 72.81% |
| FII Holding | 0.87% | 1.45% | 1.35% | 1.11% | 1.00% | 0.89% | 1.14% | 1.35% |
| DII Holding | 7.45% | 6.14% | 6.48% | 6.70% | 7.04% | 4.19% | 4.63% | 5.45% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 14.98% | 15.33% | 15.46% | 15.37% | 15.17% | 17.41% | 16.79% | 15.92% |
| Other Holding | 3.74% | 4.12% | 3.76% | 3.88% | 3.83% | 4.70% | 4.62% | 4.47% |
| Shareholder Count | 25,282 | 24,867 | 25,832 | 26,657 | 25,905 | 22,137 | 22,232 | 23,481 |
RPG Life Sciences Share Dividend Screener - Share Yield Analysis
Check RPG Life Sciences dividend history with payout and yield data.
View RPG Life Sciences dividend details including ex-dates and amounts for RPGLIFE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹24.00 | 0.80% |
| 2025-March | ₹24.00 | 1.29% |
| 2024-March | ₹16.00 | 0.70% |
| 2023-March | ₹12.00 | 0.79% |
| 2022-March | ₹9.60 | 1.40% |
| 2021-March | ₹7.20 | 1.28% |
| 2020-March | ₹4.00 | 1.03% |
| 2019-March | ₹2.40 | 1.41% |
| 2018-March | ₹2.40 | 0.97% |
| 2017-March | ₹2.80 | 0.73% |
RPG Life Sciences Stock Index Membership
See which indices include RPG Life Sciences stock.
Check RPGLIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
RPG Life Sciences Market Events Screener - Corporate Actions
Get RPG Life Sciences corporate actions including splits, bonuses, and buybacks.
Check RPG Life Sciences stock events that may affect RPGLIFE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-23 | 2026-07-23 | Annual General Meeting | NA | 32.52% |
| 2026-07-09 | 2026-07-09 | Dividend | ₹ 24.00 /share | 19.40% |
| 2026-04-29 | 2026-04-29 | Quarterly Result Announcement | NA | 3.00% |
| 2026-01-27 | 2026-01-27 | Quarterly Result Announcement | NA | -6.97% |
| 2025-10-17 | 2025-10-17 | Quarterly Result Announcement | NA | 3.21% |
| 2025-07-25 | 2025-07-25 | Quarterly Result Announcement | NA | -1.32% |
| 2025-07-16 | 2025-07-16 | Annual General Meeting | NA | 9.20% |
| 2025-06-27 | 2025-06-27 | Dividend | ₹ 20.00 /share | 8.01% |
| 2025-06-27 | 2025-06-27 | Dividend | ₹ 4.00 /share | 8.01% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | 2.14% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | 4.82% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 9.41% |
| 2024-07-16 | 2024-07-16 | Annual General Meeting | NA | 6.83% |
| 2024-06-28 | 2024-06-28 | Dividend | ₹ 16.00 /share | 2.52% |
| 2023-07-21 | 2023-07-21 | Dividend | ₹ 12.00 /share | 21.46% |
RPG Life Sciences Competitors Screener - Peer Comparison
Screen RPGLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 468,182 | 40.78 | 61,674 | 12.69% | 11,565 | 67.08 |
| Divis Laboratories | 194,150 | 75.69 | 11,067 | 13.95% | 2,568 | 71.64 |
| Torrent Pharmaceuticals | 189,762 | 79.19 | 13,886 | 20.34% | 2,138 | 65.32 |
| Cipla | 115,740 | 30.16 | 29,045 | 2.24% | 3,870 | 55.65 |
| Zydus Life Science | 115,405 | 22.33 | 27,658 | 17.64% | 5,026 | 60.58 |
| Lupin | 113,819 | 21.16 | 29,039 | 26.75% | 5,356 | 59.41 |
| Mankind Pharma | 106,396 | 54.68 | 14,636 | 14.85% | 1,938 | 59.45 |
| Dr Reddys Laboratories | 101,963 | 24.56 | 35,059 | 3.90% | 4,158 | 35.59 |
| Aurobindo Pharma | 89,592 | 25.88 | 33,385 | 3.21% | 3,376 | 55.50 |
| Laurus Labs | 85,395 | 94.61 | 6,868 | 22.01% | 890 | 63.63 |
RPG Life Sciences Company Announcements - News Screener
Screen RPGLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-18 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-18 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-02 | Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The Company | - |
| 2026-07-01 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-07-01 | Notice Of 19Th Annual General Meeting Of The Company | - |
| 2026-07-01 | Reg. 34 (1) Annual Report. | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-22 | Record Date For Determining Members Eligible To Receive Dividend For The Financial Year 2025-26. | - |
| 2026-06-12 | Clarification For Volume Movement Letter | - |
| 2026-06-12 | Clarification sought from RPG Life Sciences Ltd | - |
| 2026-06-09 | Communication To Shareholders - Intimation On Dividend Taxation Provisions | - |
| 2026-06-09 | Intimation To Shareholders Holding Shares In Physical Form For Furnishing KYC Details | - |
| 2026-06-03 | General Update | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-15 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-08 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-04-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |